eCQMs for 2020 Performance Period CMS2v9 CMS22v8 CMS50v8 CMS52v8 CMS56v8 CMS66v8 CMS68v9 CMS69v8 CMS74v9 CMS75v8 CMS82v7 CMS90v9 CMS117v8 CMS122v8 CMS124v8 CMS125v8 CMS127v8 CMS128v8 CMS129v9 CMS130v8 CMS131v8 CMS132v8 CMS133v8 CMS134v8 CMS135v8 CMS136v9 CMS137v8 CMS138v8 CMS139v8 CMS142v8 CMS143v8 CMS144v8 CMS145v8 CMS146v8 CMS147v9 CMS149v8 CMS153v8 CMS154v8 CMS155v8 CMS156v8 CMS157v8 CMS159v8 CMS160v8 CMS161v8 CMS165v8 CMS177v8 CMS249v2 CMS347v3 CMS349v2 CMS645v3 CMS771v1 CMS Measure ID CMS157v8 Version 8 NQF Number 0384e Measure Description Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified Initial Population All patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy Denominator Statement Equals Initial Population Denominator Exclusions None Numerator Statement Patient visits in which pain intensity is quantified Numerator Exclusions Not Applicable Denominator Exceptions None Measure Steward PCPI(R) Foundation (PCPI[R]) Domain Person and Caregiver-Centered Experience and Outcomes Previous Version CMS157v7 Measure Scoring Proportion Measure Type Process Improvement Notation Higher score indicates better quality Guidance This measure is an episode-of-care measure; the level of analysis for this measure is every visit for patients with a diagnosis of cancer who are also currently receiving chemotherapy or radiation therapy during the measurement period. For patients receiving radiation therapy, pain intensity should be quantified at each radiation treatment management encounter where the patient and physician have a face-to-face interaction. Due to the nature of some applicable coding related to radiation therapy (e.g., delivered in multiple fractions), the billing date for certain codes may or may not be the same as the face-to-face encounter date. In this instance, for the reporting purposes of this measure, the billing date should be used to pull the appropriate patients into the initial population. It is expected, though, that the numerator criteria would be performed at the time of the actual face-to-face encounter during the series of treatments.For patients receiving chemotherapy, pain intensity should be quantified at each face-to-face encounter with the physician while the patient is currently receiving chemotherapy. For purposes of identifying eligible encounters, patients "currently receiving chemotherapy" refers to patients administered chemotherapy within 30 days prior to the encounter AND administered chemotherapy within 30 days after the date of the encounter. Pain intensity should be quantified using a standard instrument, such as a 0-10 numerical rating scale, visual analog scale, a categorical scale, or pictorial scale. Examples include the Faces Pain Rating Scale and the Brief Pain Inventory (BPI). Quality ID 143 Meaningful Measure Management of Chronic Conditions Specifications Attachment Size CMS157v8.html 50.48 KB CMS157v8.zip 25.3 KB CMS157v8-TRN.xlsx 21.2 KB Release Notes HeaderUpdated eCQM version number.Measure Section: eCQM Version numberSource of Change: Measure LeadAdded 'e' to NQF number.Measure Section: NQF NumberSource of Change: Standards UpdateUpdated copyright.Measure Section: CopyrightSource of Change: Annual UpdateUpdated disclaimer.Measure Section: DisclaimerSource of Change: Measure LeadUpdated rationale statement in-text citation date for updated reference.Measure Section: RationaleSource of Change: Measure LeadUpdated clinical recommendation statement to align with current guideline.Measure Section: Clinical Recommendation StatementSource of Change: Measure LeadUpdated references to align with American Psychological Association (APA) style.Measure Section: ReferenceSource of Change: Measure LeadUpdated references.Measure Section: ReferenceSource of Change: Measure LeadUpdated guidance statement related to radiation treatment management CPT code (77427).Measure Section: GuidanceSource of Change: Measure LeadUpdated parenthetical citations to align with American Psychological Association (APA) style.Measure Section: Multiple SectionsSource of Change: Measure LeadLogicUpdated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide.Measure Section: Definitions and FunctionsSource of Change: Standards UpdateUpdated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3).Measure Section: Multiple SectionsSource of Change: Standards UpdateValue SetThe VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.Value set Chemotherapy Administration (2.16.840.1.113883.3.526.3.1027): Deleted 4 CPT codes (96411, 96415, 96417, 96423).Measure Section: TerminologySource of Change: Annual UpdateValue set Cancer (2.16.840.1.113883.3.526.3.1010): Added 4 SNOMED CT codes (702391001, 763131005, 764791008, 767448007) and deleted 3 SNOMED CT codes (186709004, 186723002, 186725009). Added 29 ICD-10-CM codes.Measure Section: TerminologySource of Change: Annual UpdateStandardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files.Measure Section: TerminologySource of Change: Measure Lead External Resources United States Health Information Knowledgebase NLM Value Set Authority Center (VSAC)